Description: The peptide is used to block Anti-EIF3D Antibody (#CPA5008) reactivity. Form: Lyophilized powder Gene Symbol: EIF3D Alternative Names: EIF3S7; Eukaryotic translation initiation factor 3 subunit D; eIF3d; Eukaryotic translation initiation factor 3 subunit 7; eIF-3-zeta; eIF3 p66Entrez Gene (Human): 8664Entrez Gene (Mouse) : 55944Entrez Gene (Rat) : 362952SwissProt (Human): O15371SwissProt (Mouse) : O70194SwissProt (Rat) : Q6AYK8Purity : >85%Directions for Use : Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control : The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability : Shipped at 4°C. Store at -20°C for one year.

• 
  Western blot analysis of EIF3D expression in Hela (A), NIH3T3 (B) whole cell lysates.
• 
  Immunohistochemical analysis of EIF3D staining in human lung cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugacompact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.